Adverse events reported after first dose of SARS-CoV-2 vaccine in the Northern Region of Ghana.
Nurs Open
; 10(3): 1785-1793, 2023 03.
Article
em En
| MEDLINE
| ID: mdl-36326788
ABSTRACT
AIM:
The study examined the associated adverse events following SARS-CoV-2 vaccination among healthcare workers during the first dose of the vaccine in the Northern Region of Ghana.DESIGN:
The study was a cross-sectional survey involving 463 healthcare workers.METHOD:
The data were collected using a structured questionnaire. The data were analysed descriptively, and binary logistics was performed using SPSS version 25.RESULTS:
The mean age was 33.4 ± 9.7 years, the majority (43.6%) being ≤30 years and males (57.2%). The self-reported prevalence of SARS-CoV-2 vaccine adverse events was 75.5%. Common systemic adverse events comprised headache (47.5%), dizziness (18.4%) and local adverse events included generalized body pains (44.0%) and abscess around the injection sites (11.2%). The study found a high prevalence of self-reported SARS-CoV-2 vaccine adverse events involving both systemic and local adverse events. Our study gives useful information that can be used for public health-targeted interventions to boost public confidence in SARS-CoV-2 vaccines.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Vacinas contra COVID-19
/
COVID-19
Tipo de estudo:
Qualitative_research
/
Risk_factors_studies
Limite:
Adult
/
Humans
/
Male
País como assunto:
Africa
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article